Defactinib

defactinib · Verastem, Inc.

Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for Defactinib, covering 2017-01-30 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer [Phase 2]